Evidence map›Paper›PMID 26943769›Full record

ArticleOncotarget2016

The role and potential mechanisms of LncRNA-TATDN1 on metastasis and invasion of non-small cell lung cancer.

Niu Zequn, Zhang Xuemei, Li Wei, Ming Zongjuan, Zhong Yujie, Hou Yanli, Zhang Yuping, Meng Xia, Wang Wei, Deng Wenjing and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. TCDD Toxicity Mediated by Epigenetic Mechanisms.International journal of molecular sciences · 2018
    Review
  13. Article
  14. Article
  15. Article
  16. [Advances in Long Non-coding RNAs on Resistant to EGFR-TKIs 
in Non-small Cell Lung Cancer].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2018
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Niu ZequnInstitute of Respiratory Medicine, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Zhang XuemeiInstitute of Pediatric Hematology and Oncology Medicine, Shanghai Oriental Hospital, Shanghai, China.
Li WeiInstitute of Respiratory Medicine, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Ming ZongjuanInstitute of Respiratory Medicine, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Zhong YujieInstitute of Respiratory Medicine, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Hou YanliInstitute of Respiratory Medicine, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Zhang YupingInstitute of Respiratory Medicine, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Meng XiaInstitute of Respiratory Medicine, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Wang WeiInstitute of Respiratory Medicine, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Deng WenjingInstitute of Respiratory Medicine, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Fan NaInstitute of Respiratory Medicine, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Yang ShuanyingInstitute of Respiratory Medicine, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Second Affiliated Hospital of Xi'an Jiaotong University · CNLianyungang Oriental Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The invasion and metastasis of malignant tumor cells lead to normal tissue destruction and are major prognostic factors for many malignant cancers. Long non-coding RNA (LncRNA) is associated with occurrence, development and prognoses of non-small cell lung cancer (NSCLC), but its mechanisms of action involved in tumor invasion and metastasis are not clear. In this study, we screened and detected the expression of LncRNA in two NSCLC lines 95D and 95C by using high throughput LncRNA chip. We found that TATDN1 (Homo sapiens TatD DNase domain containing 1, TATDN1), one of LncRNAs, was highly expressed in 95D cells and NSCLC tumor tissues compared to 95C cells. Knockdown of TATDN1-1 by shRNA significantly inhibited cell proliferation, adhesion, migration and invasion in 95D cells. Further mechanism study showed that TATDN1 knockdown suppressed the expression of E-cadherin, HER2, β-catenin and Ezrin. Moreover, knockdown TATDN1 also inhibited tumor growth and metastasis in a 95D mouse model in vivo by inhibiting β-catenin and Ezrin. These data indicate that TATDN1 expression is associated with 95D cells' higher potential of invasion and metastasis, and suggest that TATDN1 may be a potential prognostic factor and therapeutic target for NSCLCs.

Indexed as

Animalsbeta CateninCadherinsCarcinoma, Non-Small-Cell LungCell Line, TumorCytoskeletal ProteinsErb-b2 Receptor Tyrosine KinasesEzrinHumansLung NeoplasmsMaleMiceMice, Inbred BALB CMice, NudeNeoplasm InvasivenessRNA Interferencebeta CateninCadherinsCytoskeletal ProteinsERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesEzrinlong non-coding RNA TATDN1, humanRNA, Long NoncodingRNA, Small InterferinginvasionLncRNAmetastasisnon-small cell lung cancerTATDN1

Identifiers

PMID26943769
PMCPMC4951283
OpenAlexW2341512205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.